Sapna W. Palla PARTNER spalla@wiggin.com New York: +1 212 551 2844 Sapna is a Partner in the firm's Litigation Department and Intellectual Property Practice Group. Sapna has spent nearly two decades representing clients in patent, trademark, copyright, and complex commercial matters, including successfully litigating disputes in a range of jurisdictions. They include the Federal Circuit and federal courts in Delaware, the District of New Jersey, the Eastern District of Virginia, the Eastern District of Texas, the Southern District of New York, the Southern District of Florida, the Northern District of California, the District of Maryland, the District of Minnesota, and the Western District of Wisconsin. She also has extensive experience with alternative dispute resolution, including arbitration and mediation. Sapna also counsels and represents a variety of U.S. and international clients regarding U.S. intellectual property by providing them with infringement, validity, enforceability, and clearance opinions and by advising them in licensing and antitrust matters. She also has conducted intellectual property due diligence investigations in connection with acquisitions and licensing deals, and she has represented clients in proceedings before the U.S. Patent Office. Sapna also counsels clients about patent law in Asia, including China and India. Sapna's patent experience covers a broad array of technologies, including pharmaceuticals, biotechnology, drug delivery systems and medical devices, mechanical devices, batteries, software, and agrochemicals. Outside the patent area, Sapna has represented clients in trademark, trade dress, and copyright litigation as well as in counseling clients on trademark and copyright registration, strategy, and licensing. Sapna has also handled a number of complex commercial disputes involving complex contractual matters in the oil, renewable energy, construction, and food services industries. Sapna frequently writes and speaks on a range of topics, including developments in litigation, e-discovery, patent law, patent reform, intellectual property law in Asia, pharmaceuticals, biosimilars, biotechnology, and medical devices. Her programs have been presented by the Practicing Law Institute and WestLegal Ed, and she has been published and quoted in leading publications, including Practicing Law Institute, Forbes, ABA Litigation Journal, IP Law360, New York Law Journal, Corporate Counsel Connect, Pharmaceutical Patent Analyst, and Bloomberg/BNA.
She is an adjunct professor at Pace University School of Law, addressing antitrust and patent topics. She clerked for the Honorable Judge Robert J. Hurley of the U.S. District Court for the Eastern District of New York. Sapna is committed to pro bono legal services. In 2008, she was honored by the Pennsylvania Capital Representative Project for extraordinary efforts on behalf of Pennsylvania's death row inmates. In 2001, she received the Legal Aid Society award for Outstanding Pro Bono Representation. Sapna is on the board of directors of the Asian American Bar Association of New York (AABANY) and the AABANY Leadership Development Institute. Previously she was a Co-chair of its Women's Committee. Sapna is an inaugural member of Judge Janet Bond Arterton's Intellectual Property American Inns of Court and is also a member of the New York Intellectual Property Association and its Litigation and Legislative Action Committees. Sapna received her J.D. summa cum laude from Pace University School of Law, where she was Notes and Comments Editor at the Pace Environmental Law Review. She received her B.B.A. magna cum laude in international management with pre-medical concentration from Pace University, where she received the Medal for Distinction in University Honors Program and a Medal for Outstanding Scholarship in International Management. Sapna has lived and studied in both India and Tanzania. She is fluent in Hindi and Marathi and conversant in French. Education Pace University School of Law (J.D., 1998) o summa cum laude Pace University (B.B.A, 1995) o magna cum laude Bar Admissions New York Court Admissions US Court of Appeals for the Federal Circuit US District Court (Southern District of New York) Memberships and Affiliations Intellectual Property Organization o Asia Practice Group New York Intellectual Property Law Association Asian Bar Association of New York
o o Intellectual Property Litigation National Association of Pacific American Bar Association Languages French Marathi Hindi Experience Successfully defended and obtained favorable settlement in a patent infringement challenge involving biotechnology research tools. Genovis AB et al. v. Promega Corporation (W. D. Wis). Successfully defeated an ANDA challenge in the U.S. District Court for the District of Delaware for pharmaceutical clients concerning Tarceva for treating non-small-cell lung cancer. After a five-day bench trial, the court ruled that the two patents covering Tarceva and its use were not invalid. OSI Pharmaceuticals Inc. et al. v. Mylan Pharmaceuticals Inc. (D. Del.). Secured a favorable jury verdict for a French multinational pharmaceutical company in a suit against a pharmaceutical company, in the U.S. District Court for the District of New Jersey. The jury confirmed the validity of the Sanofi-Aventis Deutschland GmbH patent for Tarka and awarded $16 million in damages. Sanofi-Aventis Deutschland GmbH et al. v. Glenmark Pharmaceuticals Inc. USA et al. (D. N.J.). Represented The Taunton Press Inc. in a trademark infringement and preliminary injunction action. MacDonald et al. v. WGBH Educational Foundation, The Taunton Press, Inc. et al. (D. Mass.) Obtained favorable settlement for the defendant in a trade dress infringement and preliminary injunction action against General Mills involving its LÄRABAR packaging design. General Mills, Inc. v. Rawbite APS et al. (D. Minn). Publications March 4, 2019 Recent Developments in Intellectual Property Law Newsletter November 13, 2018 Legal Issues for High-Growth Technology Companies The National Law Review
July 11, 2018 The Patent Eligibility Battle for Life Sciences Companies in a Changing Landscape The National Law Review March 12, 2018 Recent Developments in Intellectual Property Law December 15, 2017 Intellectual Property Group Practice Update & Recent Happenings August 4, 2017 What To Watch As FDA Begins To Fight Rising Drug Prices Law360, New York July 17, 2017 How to Shift Your Litigation Strategies For the New IP Landscape New York Law Journal June 1, 2017 U.S. Supreme Court Broadens the Patent Exhaustion Doctrine in Impression Products v. Lexmark Int'l, Inc. May 22, 2017 Supreme Court Drastically Limits Venue for Patent Cases March 23, 2017 U.S. Supreme Court Eliminates Defense of Laches In Patent Infringement Cases February 28, 2017 Extraterritoriality of United States Patent Laws: Limited Infringement Liability January 24, 2017 The Year In Intellectual Property: A Look Back at 2016 and a Look Ahead to 2017 December 6, 2016 Supreme Court Decision Regarding Damages for Design Patent Infringement September 1, 2016 Global IP Trends: A Guide to Recent International Considerations for Patent Rights Corporate Counsel Connect June 29, 2016 Busy Supreme Court Docket in Intellectual Property Highlighted by Cases on Enhanced Damages, Attorney's Fees, Claim Construction Standard in IPRs, and Extraterritoriality February 4, 2016 The New Biosimilars Frontier
American Bar Association January 29, 2016 Intellectual Property 2015 Year In Review January 22, 2015 Supreme Court Changes Appellate Review Standard for Claim Construction January 12, 2015 Intellectual Property 2014 Year in Review June 20, 2014 Abstract Ideas Require Something More than Implementation on Generic Computer to be Patent Eligible April 14, 2014 Licensing In the European Union: The European Commission Adopts New Regulations and Guidelines for Applying EU Competition Law To Technology Transfer Agreements March 1, 2013 Devising a Patent Strategy to Protect The Intellectual Property of Biologics in Light of Ambiguities, Loopholes, and Pitfalls in The Regulatory Scheme Pharm Pat. Analyst November 1, 2012 Best Mode, Chapter for Pharmaceutical and Biotech Patent Law Practicing Law Institute September 1, 2012 Patent Invalidity Rates in Japan White Paper, Intellectual Property Organization September 1, 2012 Patent Invalidity Rates in China White Paper, Intellectual Property Organization January 23, 2012 Should the Federal Circuit's Model E-Discovery Order Change the Way you Conduct E-Discovery for Patent Litigation? Bloomberg Law May 1, 2009 Understanding the voluntary Carbon Market: Why Companies Buy Carbon Credits, Why the Voluntary Market Will Coexist with Future Mandatory Regulation, and Why Contracts Should Allocate Carbon Credit Ownership Bloomberg Law Reports - Sustainable Energy